{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:07:03Z","timestamp":1789020423930,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cholangitis is one of the most common and serious complications following Kasai portoenterostomy (KP) in patients with biliary atresia (BA). There is heterogeneity in antibiotic usage protocols across centers, and the efficacy of prophylactic oral antibiotics in preventing cholangitis remains unclear. This study aimed to assess the efficacy of prophylactic oral antibiotics in preventing cholangitis after KP in patients with BA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted, incorporating all eligible studies published or presented as abstracts from inception to July 6th, 2026. Inclusion criteria required original data comparing the incidence of cholangitis in BA patients who received prophylactic oral antibiotics after KP versus those who did not receive. The primary outcome was the incidence of cholangitis within the follow-up period. Secondary outcomes included the native liver survival (NLS) rate and jaundice clearance rate. Subgroup analysis was conducted in the incidence of cholangitis according to study design [randomized controlled trial (RCT) and retrospective cohort vs. cross-sectional]. The Cochrane Risk of Bias tool, Newcastle-Ottawa Scale (NOS), and NOS-xs were used to assess the risk of bias. Heterogeneity among studies was assessed by the chi-square test, and the random-effects model or the fixed-effects model was selected according to heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six studies, comprising 516 BA patients, met eligibility criteria. No statistically significant difference was observed in the incidence of cholangitis between the antibiotics and non-antibiotics groups [56.91% (177\/311) vs. 56.59% (116\/205),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.75, OR=0.88, 95% CI: 0.41\u20131.92]. Similar results were found in subgroup analysis. In contrast, the NLS rate was significantly lower in the non-antibiotics group [54.35% (75\/138) vs. 36.17% (34\/94),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006, OR=2.15, 95% CI: 1.25\u20133.69]. Jaundice clearance rates did not differ significantly between the antibiotics and non-antibiotics groups [42.71% (85\/199) vs. 38.56% (59\/153),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.94, OR=0.97, 95% CI: 0.40\u20132.34].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence does not support the protective effect of prophylactic oral antibiotics against cholangitis following KP in BA. Further high-quality, prospective randomized controlled trials are warranted to clarify causality and optimize antibiotic stewardship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1935772","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:54Z","timestamp":1789018314000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic oral antibiotic use for the prevention of cholangitis after Kasai portoenterostomy in patients with biliary atresia: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Di","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, Children\u2019s Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Children\u2019s Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","first-page":"245","article-title":"Evidence-based practice guideline on the diagnosis and treatment of biliary atresia","volume":"17","author":"Chen","year":"2022","journal-title":"Chinese Journal of Evidence-Based Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21037\/tp.2016.10.08","article-title":"Adjuvant treatments for biliary atresia","volume":"9","author":"Burns","year":"2020","journal-title":"Transl Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/s0140-6736(09)60946-6","article-title":"Biliary atresia","volume":"374","author":"Hartley","year":"2009","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/jcm11030494","article-title":"Cholangitis definition and treatment after Kasai hepatoportoenterostomy for biliary atresia: a Delphi process and international expert panel","volume":"11","author":"Calinescu","year":"2022","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00383-021-04916-z","article-title":"Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia: a randomized controlled trial","volume":"37","author":"Chen","year":"2021","journal-title":"Pediatr Surg Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0009922815594760","article-title":"Prophylactic antibiotics for prevention of cholangitis in patients with biliary atresia status post-Kasai portoenterostomy: a systematic review","volume":"55","author":"Decharun","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jpids\/piae028","article-title":"Where did this come from?\": antibiotic prophylaxis in biliary atresia after Kasai procedure","volume":"13","author":"Ravanbakhsh","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/jpsu.2003.50128","article-title":"Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy","volume":"38","author":"Bu","year":"2003","journal-title":"J Pediatr Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/MPG.0000000000003935","article-title":"Prophylactic antibiotics to prevent cholangitis in children with biliary atresia after Kasai portoenterostomy: a meta-analysis","volume":"77","author":"Alatas","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jre.13405","article-title":"Risk of bias evaluation of cross-sectional studies: adaptation of the Newcastle-Ottawa scale","author":"Carra","year":"2025","journal-title":"J Periodontal Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/archpedi.1976.02120090040007","article-title":"Congenital biliary atresia: analysis of 97 cases with reference to prognosis after hepatic portoenterostomy","volume":"130","author":"Kobayashi","year":"1976","journal-title":"Am J Dis Child"},{"key":"B13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/MPG.0000000000000676","article-title":"Use of Lactobacillus casei rhamnosus to prevent cholangitis in biliary atresia after Kasai operation","volume":"60","author":"Lien","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/S0168-8278(86)80316-6","article-title":"Antibiotic prophylaxis of cholangitis in biliary atresia: a prospective randomised trial of septrin after portoenterostomy","volume":"3","author":"Howard","year":"1986","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1542\/peds.83.5.723","article-title":"Perioperative factors affecting the outcome following repair of biliary atresia","volume":"83","author":"Lally","year":"1989","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jpeds.2011.09.061","article-title":"Biliary atresia in The Netherlands: outcome of patients diagnosed between 1987 and 2008","volume":"160","author":"de Vries","year":"2012","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/ped.12737","article-title":"Serum bacterial DNA detection in patients with cholangitis after Kasai procedure","volume":"57","author":"Luo","year":"2015","journal-title":"Pediatr Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MPG.0000000000002837","article-title":"Does the treatment after Kasai procedure influence biliary atresia outcome and native liver survival?","volume":"71","author":"Pietrobattista","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/apa.17493","article-title":"Primary antibiotic prophylaxis in biliary atresia did not demonstrate decreased infection rate: multi-centre retrospective study","volume":"114","author":"Brody","year":"2025","journal-title":"Acta Paediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12519-008-0003-0","article-title":"Current concept about postoperative cholangitis in biliary atresia","volume":"4","author":"Luo","year":"2008","journal-title":"World J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jpedsurg.2017.01.041","article-title":"Variability of diagnostic approach, surgical technique, and medical management for children with biliary atresia in Canada: is it time for standardization?","volume":"52","author":"Stagg","year":"2017","journal-title":"J Pediatr Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0038-1668146","article-title":"What happens after Kasai for biliary atresia? A European multicenter survey","volume":"29","author":"Wong","year":"2019","journal-title":"Eur J Pediatr Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jpeds.2005.12.054","article-title":"A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000","volume":"148","author":"Shneider","year":"2006","journal-title":"J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jpeds.2014.05.038","article-title":"Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a north American multicenter consortium","volume":"165","author":"Ng","year":"2014","journal-title":"J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9726","DOI":"10.1097\/JS9.0000000000003227","article-title":"Risk factors for cholangitis after Kasai procedure in biliary atresia patients: a systematic review and meta-analysis","volume":"111","author":"Liu","year":"2025","journal-title":"Int J Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/MPG.0000000000003446","article-title":"The effect of prophylactic antibiotics in the prevention of cholangitis in post-Kasai portoenterostomy biliary atresia patients: a systematic review","volume":"74","author":"Mallari","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhbp.512","article-title":"Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)","volume":"25","author":"Kiriyama","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1935772\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:31:55Z","timestamp":1789018315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1935772\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":27,"alternative-id":["10.3389\/fped.2026.1935772"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1935772","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1935772"}}